Přihlásit se Zaregistrujte se zdarma

Návratnost aktiv společnosti 4SC AG

Jaká je hodnota metriky Návratnost aktiv společnosti 4SC AG?

Hodnota metriky Návratnost aktiv společnosti 4SC AG je -25.63%

Jaká je definice metriky Návratnost aktiv?



Návratnost aktiv (Return on assets - ROA) je rentabilita aktiv. Vypočítá se vydělením celkového příjmu průměrem celkových aktiv.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Návratnost aktiv společností v sektoru Health Care sektor na XETRA ve srovnání se společností 4SC AG

Čemu se věnuje společnost 4SC AG?

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

Firmy s metrikou návratnost aktiv podobnou společnosti 4SC AG